JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(1):18-23

Consumption of Antiepileptics in 1993-2004 Using Various Methods

B. Kořístková, M. Grundmann
Fakultní nemocnice v Ostravě a Zdravotně sociální fakulta Ostravské univerzity v Ostravě, Ústav klinické farmakologie

Drug utilization expresses the exposition of a drug in the relationship with determined population, certain time period, and specific socioeconomic background. The aim of this study was to compare the antiepileptic drug utilization (N03A) in the Czech Republic (CR) and in Ostrava University Hospital (FNsP). The sources of the data were I) wholesale data (SUKL, CR), II) prescriptions (UZIS, CR), III) request forms (FNsP), IV) request forms for therapeutic drug monitoring (FNsP). The utilization was expressed in DDD/TID (I, II), or in DDD/100 BD in neurological departments (III) on 5th or 4th level, resp. ATC/DDD index 2001, for levetiracetam 2004. Carbamazepine had the highest utilization that was increasing in the CR, while remaining high and constant in FNsP. The utilization of valproic acid is increasing. The number of patients shows greater prescription than utilization in DDD. The utilization of phenytoin was high in the CR, but diminished in FNsP. The number of patients was lower than expected. The utilization of barbiturates was considerable in the CR, but below the average in FNsP. The utilization of clonazepam and N03AX was increasing. The most important substance there was lamotrigin. The outcomes are in agreement with current recommendations. The utilization in FNsP and CR follows the same trend with a faster shift to newer drugs in FNsP.

Keywords: antiepileptics; DDD, TID; DDD, 100 BD; utilization; comparison

Received: June 13, 2005; Accepted: September 20, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kořístková B, Grundmann M. Consumption of Antiepileptics in 1993-2004 Using Various Methods. Čes. slov. farm. 2006;55(1):18-23.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Vlček, J., Macek, K., Müllerová, H.: Farmakoepidemiologie, farmakoekonomika, farmakoinformatika. Základy pro farmaceuty. 1. vyd. Praha, Panax Co, 1999, s. 82.
    2. Jirout, J.: Českoslov. Farm., 1970; 19: 281. Go to original source...
    3. WHO Collaborating Centre for Drug Statistics Methodology: Guidelines for ATC classification and DDD assignment, 4. vyd. Oslo, Norway, WHO, 2001, 11-13.
    4. Kořístková, B.: In: European Collaboration: Towards Drug Development and Rational Drug Therapy. The Proceedings of the Sixth Congress of the European Association for Clinical Pharmacology and Therapeutics, Istanbul, June 24-28, 2003 (Tulunay, F. C., Orme, M. eds.), Berlin-Heidelberg, Springer-Verlag, 2003, s. 37.
    5. WHO Collaborating Centre for Drug Statistics Methodology: ATC index with DDDs 2001, Oslo, Norway, 2001, 129-130.
    6. Státní ústav pro kontrolu léčiv. SEZNAM registrovaných léčivých přípravků a přípravků, kterým byla povolena výjimka MZ ČR. http://www.sukl.cz/02.htm
    7. www.whocc.no/atcddd/
    8. Komárek, V.: Medicína po promoci, 2002; 6, 54.
    9. Kořístková, B., Bergman, U., Sjöquist, F., Grundmann, M.: In: Abstract-book V. Congress EURODURG, June 2001. Praha, Galén, 2001, s. 67.
    10. Kořístková, B., Grundmann, M., Bergman, U., Sjöqvist, F.: In: European Collaboration: Towards Drug Development and Rational Drug Therapy. The Proceedings of the Sixth Congress of the European Association for Clinical Pharmacology and Therapeutics, Istanbul, June 24-28, 2003 (Tulunay, F. C., Orme, M. eds.), BerlinHeidelberg, Springer-Verlag, 2003, s. 148.
    11. Gábová, M.: Diplomová práce. Hradec Králové, Kat. soc. a klin. farmacie, Farmaceutická fakulta Univerzity Karlovy, 1999.
    12. Dvořáček, L., Knedlíková, H., Grundmann, M.: In.: Abstrakta VII.pracovní konference o terapeutickém monotorování hladin léků (TDM), IV. pracovní konference DURG a II. pracovní konference klinické farmakologie, Rožnov pod Radhoštěm 28.-30. 9. 2000, ISBN 807042-323-4, s. 14-15.
    13. Kořístková, B., Grundmann, M.: Čes. a Slov. Farm., 2005; 54, 130-136. Go to original source...
    14. Rochat, P., Hallas, J., Gaist, D., Friis, M. L.: Acta Neurol. Scand., 2001; 104, 6-11. Go to original source... Go to PubMed...
    15. Shackleton, D. P. et al.: J. Clin. Epidemiol., 1997; 50, 1061-1068. Go to original source... Go to PubMed...
    16. Peytchev, L., Atansova, I., Terziivanov, D.: Int. J. Clin. Pharmacol. Ther., 1996; 34, 444-445. Go to original source...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.